Cloudbreak is a clinical-stage biotechnology company that develops and commercializes ocular drugs for ophthalmic diseases... Read more
Cloudbreak is a clinical-stage biotechnology company that develops and commercializes ocular drugs for ophthalmic diseases... Read more
Co-Founder & CEO
Jinsong Ni
News
Apr 17, 2020
ChinaBio Today
Cloudbreak: Cloudbreak, a US-China Biopharma, Raises $25 Million for Ophthalmology Drugs
Apr 17, 2020
China Money Network
Cloudbreak: V-Capital Leads $25M New Round In Ocular Drug Developer Cloudbreak Therapeutics
Apr 17, 2020
firstwordpharma
Cloudbreak: V-Capital Leads $25M New Round In Ocular Drug Developer Cloudbreak Therapeutics - (China Money Network via NewsPoints Desk)
Cloudbreak Therapeutics Competitors
1
2
3
4
5
6
7
8
9
10